Study: Intravenous ketamine effective against treatment-resistant major depression

Source: United Press International

“Ketamine may be an alternative to shock treatment for people with treatment-resistant major depression, a new study suggests. Currently, patients with major depressive disorder who don’t find a medication or therapy that works may undergo electroconvulsive therapy (ECT), also known as shock therapy. But researchers have also been studying intravenous ketamine — a powerful anesthetic that’s also long been used as an illicit ‘party’ drug — as a potential antidepressant. … The study found the antidepressant response rate for patients with IV ketamine was 55%. For those receiving ECT, the response rate was 41%.” (05/25/23)